Is the 'Golden Age' of antiobotics in our rearview mirror?

Caitlin Wilson | | Health Exec | Precision Medicine

Some experts are now saying the “golden age of antibiotics” is behind us, according to the Los Angeles Times. The ability to stop a bacterial infection in its tracks is a thing of the past, because more and more antibiotic-resistant gene markers are showing up in bacteria in the U.S.

One particularly worrying sign is that a colistin-resistant gene was found in the E. coli bacteria from an infected woman in the U.S. That gene could move to other similar (or even not similar) bacteria and spread, infecting more people without the ability to treat them.

Check out the story in the Los Angeles Times for more info on how we got here and what comes next.  

A 'slow catastrophe' unfolds as the golden age of antibiotics comes to an end

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”